These results suggest that a long-term surveillance strategy with reduced frequency, rather than intensive short-term monitoring, may be appropriate for patients with MEN1-related PAs, particularly for those with micro-PRLomas. Here, MEN1 is linked to prolactin-producing pituitary gland adenoma.